Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.
ConditionCOPD Exacerbation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorAlexis FERRE
About this trial
The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU
Eligibility criteria
Qualifiers
Age ≥ 40 years old
COPD documented or strongly suspected
Chronic respiratory symptoms (dyspnoea, cough and/or sputum)
Exposure to a known risk factor for COPD (such as tobacco smoke)
Disqualifiers
Known asthma (according to the criteria of the international "Global initiative for asthma" guidelines)
Patient refusal to participate (information note, application for non-opposition)
Trial design
Treatments tested in this trial
- register
Treatment groups
No treatment groups listed
Sponsors and collaborators
Alexis FERRE
Lead sponsor
Versailles Hospital
Sponsor institution
Source ClinicalTrials.gov